• Citer

Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

par Catimel, G;Verweij, Jaap;Mattijssen, V;Hanauske, Axel-R;Piccart-Gebhart, Martine ;Wanders, Jantien;Franklin, H;Le Bail, N;Clavel, Michel;Kaye, S B
Référence Annals of oncology, 5, 6, page (533-537)
Publication Publié, 1994-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
Auteur:	Catimel, G; Verweij, Jaap; Mattijssen, V; Hanauske, Axel-R; Piccart-Gebhart, Martine; Wanders, Jantien; Franklin, H; Le Bail, N; Clavel, Michel; Kaye, S B
Informations sur la publication:	Annals of oncology, 5, 6, page (533-537)
Statut de publication:	Publié, 1994-07
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Docetaxel
	Head and neck cancer
	Phase II trial
MeSH keywords:	Adult
	Aged
	Alopecia -- chemically induced
	Antineoplastic Agents, Phytogenic -- administration & dosage
	Antineoplastic Agents, Phytogenic -- adverse effects
	Antineoplastic Agents, Phytogenic -- therapeutic use
	Asthenia -- chemically induced
	Carcinoma, Squamous Cell -- drug therapy
	Drug Administration Schedule
	Europe
	Female
	Head and Neck Neoplasms -- drug therapy
	Humans
	Male
	Middle Aged
	Neutropenia -- chemically induced
	Paclitaxel -- administration & dosage
	Paclitaxel -- adverse effects
	Paclitaxel -- analogs & derivatives
	Paclitaxel -- therapeutic use
	Remission Induction
	Taxoids
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Journal Article
	Multicenter Study
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:scp/0028472918
	info:pmid/7918125